19 September 2008
Interim Results for the six months to 30 June 2008
Futura Medical plc (AIM: FUM), the pharmaceutical group that develops innovative products for consumer healthcare, is pleased to announce its Interim Results for the six months to 30 June 2008.
Highlights
- Substantial progress across the Company as it moves closer to regulatory approval of its first condom product, CSD500
- CSD500 - Regulatory progress with further meeting and clarification of regulatory requirements
- TPR100 - Phase I clinical study completed with report being finalised
- PET500 - Phase I clinical study commenced
- Pre-tax loss of £1.1 million for the six months ended 30 June 2008 (six months ended 30 June 2007: pre-tax loss of £1.2 million
- Cash including medium term deposits and equity facility of £2.7 million at 30 June 2008 (31 December 2007: £2.7 million)
James Barder, Futura's Chief Executive, said:
"We are confident that Futura is on the threshold of obtaining EU marketing approval for CSD500, with the subsequent commercial launch of the product as a Durex® branded condom by SSL. We are making good progress with the other products in our pipeline of opportunities and, given our good cash position and annualised cost savings, we are able to look to the future with growing confidence."
The full results are available to download in PDF format.
For further information please contact:
Futura Medical plc
James Barder, Chief Executive
+44 (0) 1483 685 670
james.barder@futuramedical.com
www.futuramedical.com
Nominated Adviser:
Nomura Code Securities Limited
Phil Walker / Giles Balleny
Tel: +44 (0) 20 7776 1200
For media enquiries please contact:
Buchanan Communications Limited
Mark Court / Stasa Filiplic / George Prassas
Tel: +44 (0) 20 7466 5000
Notes to Editors
Futura Medical plc
Futura Medical is a pharmaceutical group that develops innovative products for consumer healthcare. The Company is developing a portfolio of products and its strategy is to license their manufacture and distribution to major pharmaceutical and healthcare groups.
Futura is based in Guildford, Surrey, and its shares trade on the AIM market of
the London Stock Exchange.